𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO)

✍ Scribed by Jason A. Zell, Bruce S. Lin, Nikki Madson, Christine E. McLaren, Eugene W. Gerner, Frank L. Meyskens


Book ID
118797076
Publisher
Springer Netherlands
Year
2012
Tongue
English
Weight
174 KB
Volume
23
Category
Article
ISSN
0957-5243

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A propspective clinical trial of difluor
✍ Charles L. Loprinzl; Edward M. Messing πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 294 KB

Difluoromethylornithine (DFMO) is a promising chemopreventive agent which is excreted unchanged in the urine, is active in vivo against superficial bladder cancer in animal tumor model systems, and has cytotoxic activity in viffo against superficial bladder cancer cells. Thus, DFMO may be particular